References
- Hamblin TJ. Autoimmune complications of chronic lymphocytic leukemia. Semin Oncol 2006;33:230–239.
- Hodgson K, Ferrer G, Montserrat E, et al. Chronic lymphocytic leukemia and autoimmunity: a systematic review. Haematologica 2011;96:752–761.
- D’Arena G, Cascavilla N. Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leuk Lymphoma 2007;48:1072–1080.
- Galletti J, Canones C, Morande P, et al. Chronic lymphocytic leukemia cells bind and present the erythrocyte protein band 3: possible role as initiators of autoimmune hemolytic anemia. J Immunol 2008;181:3674–3683.
- Wang DN. Band 3 protein: structure, flexibility and function. FEBS Lett 1994;346:26–31.
- Tanner MJ. Band 3 anion exchanger and its involvement in erythrocyte and kidney disorders. Curr Opin Hematol 2002;9:133–139.
- Beppu M, Ando K, Kikugawa K. Poly-N-acetyllactosaminyl saccharide chains of band 3 as determinants for anti-band 3 autoantibody binding to senescent and oxidized erythrocytes. Cell Mol Biol (Noisy-le-grand) 1996;42:1007–1024.
- Zhang D, Kiyatkin A, Bolin JT, et al. Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood 2000;96:2925–2933.
- Crandall I, Sherman IW. Antibodies to synthetic peptides based on band 3 motifs react specifically with Plasmodium falciparum (human malaria)-infected erythrocytes and block cytoadherence. Parasitology 1994;108:389–396.
- Hirano K, Miki Y, Hirai Y, et al. A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. J Biol Chem 2005;280:39284–39293.
- Rutella S, Rumi C, Puggioni P, et al. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Haematologica 1999;84:419–424.
- Otake Y, Soundararajan S, Sengupta TK, et al. Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood 2007;109:3069–3075.
- Ding Y, Jiang W, Su Y, et al. Expression and purification of recombinant cytoplasmic domain of human erythrocyte band 3 with hexahistidine tag or chitin-binding tag in Escherichia coli. Protein Expr Purif 2004;34:167–175.
- Casey JR, Lieberman DM, Reithmeier RA. Purification and characterization of band 3 protein. Methods Enzymol 1989;173: 494–512.
- Yu J, Fischman DA, Steck TL. Selective solubilization of proteins and phospholipids from red blood cell membranes by nonionic detergents. J Supramol Struct 1973;1:233–248.
- Crawford MP, Yan SX, Ortega SB, et al. High prevalence of autoreactive, neuroantigen-specific CD8 + T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 2004;103:4222–4231.
- Venken K, Thewissen M, Hellings N, et al. A CFSE based assay for measuring CD4 + CD25+ regulatory T cell mediated suppression of auto-antigen specific and polyclonal T cell responses. J Immunol Methods 2007;322:1–11.
- Feng Y, Huang N, Wu Q, et al. HMGN2: a novel antimicrobial effector molecule of human mononuclear leukocytes? J Leukoc Biol 2005;78:1136–1141.
- Bustin M, Trieschmann L, Postnikov YV. The HMG-14/-17 chromosomal protein family: architectural elements that enhance transcription from chromatin templates. Semin Cell Biol 1995;6: 247–255.
- Pogna EA, Clayton AL, Mahadevan LC. Signalling to chromatin through post-translational modifications of HMGN. Biochim Biophys Acta 2010;1799:93–100.
- Yang D, Postnikov YV, Li Y, et al. High-mobility group nucleosome-binding protein 1 acts as an alarmin and is critical for lipopolysaccharide-induced immune responses. J Exp Med 2012;209: 157–171.
- Feng Y, He F, Zhang P, et al. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line. Antiviral Res 2009;81:277–282.
- Feng Y, Huang N, Wu Q, et al. Alpha-helical domain is essential for antimicrobial activity of high mobility group nucleosomal binding domain 2 (HMGN2). Acta Pharmacol Sin 2005;26:1087–1092.
- Wu G, Cao Y, Fan B, et al. High-mobility group protein N2 (HMGN2) inhibited the internalization of Klebsiella pneumoniae into cultured bladder epithelial cells. Acta Biochim Biophys Sin (Shanghai) 2011;43:680–687.
- Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418: 191–195.
- Andersson U, Rauvala H. Introduction: HMGB1 in inflammation and innate immunity. J Intern Med 2011;270:296–300.
- Andriani A, Bibas M, Callea V, et al. Autoimmune hemolytic anemia during alpha interferon treatment in nine patients with hematological diseases. Haematologica 1996;81:258–260.
- Kozlowski LP, Bujnicki JM. MetaDisorder: a meta-server for the prediction of intrinsic disorder in proteins. BMC Bioinformatics 2012;13:111.
- Tomasinsig L, Skerlavaj B, Papo N, et al. Mechanistic and functional studies of the interaction of a proline-rich antimicrobial peptide with mammalian cells. J Biol Chem 2006;281:383–391.
- Darré L, Tek A, Baaden M, et al. Mixing atomistic and coarse grain solvation models for MD simulations: let WT4 handle the bulk. J Chem Theory Comput 2012;8:3880.